Drug class
Smoking Deterrents - Nicotine Patches, Transdermal
The classification "Smoking Deterrents - Nicotine Patches, Transdermal" is a compendial and formulary administrative category representing transdermal nicotine replacement therapy systems. Read more about Smoking Deterrents - Nicotine Patches, Transdermal
25 drugs in this class 23 manufacturers
Drugs in Smoking Deterrents - Nicotine Patches, Transdermal
NICOTINE PATCH (nicotine)
NICOTINE
NICODERM CQ (nicotine)
NICOTINE PATCH (nicotine)
NICOTINE PATCH (nicotine)
NICOTINE PATCH (nicotine)
NICOTINE PATCH (nicotine)
NICOTINE PATCH (nicotine)
The classification "Smoking Deterrents - Nicotine Patches, Transdermal" is a compendial and formulary administrative category representing transdermal nicotine replacement therapy systems.
These agents act as selective agonists at central and peripheral nicotinic acetylcholine receptors, delivering continuous, low levels of nicotine through the skin to alleviate cravings and physiological withdrawal symptoms without exposing patients to toxic combustion products.
Transdermal nicotine patches are primarily indicated as pharmacological adjuncts for the management of tobacco use disorder and nicotine dependence in individuals undergoing smoking cessation.
-
valdosta.edu
The classification "Smoking Deterrents - Nicotine Patches, Transdermal" is a compendial and formulary administrative category representing transdermal nicotine replacement therapy systems These agents act as selective agonists at central and peripheral nicotinic acetylcholine receptors, delivering continuous, low levels of nicotine through the skin to alleviate cravings and physiological withdrawal symptoms without exposing patients to toxic combustion products
-
nih.gov
The classification "Smoking Deterrents - Nicotine Patches, Transdermal" is a compendial and formulary administrative category representing transdermal nicotine replacement therapy systems
-
medlineplus.gov
These agents act as selective agonists at central and peripheral nicotinic acetylcholine receptors, delivering continuous, low levels of nicotine through the skin to alleviate cravings and physiological withdrawal symptoms without exposing patients to toxic combustion products Transdermal nicotine patches are primarily indicated as pharmacological adjuncts for the management of tobacco use disorder and nicotine dependence in individuals undergoing smoking cessation
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.